Literature DB >> 24481780

Epigenetic induction of tissue inhibitor of matrix metalloproteinase-3 by green tea polyphenols in breast cancer cells.

Gauri Deb1, Vijay S Thakur, Anil M Limaye, Sanjay Gupta.   

Abstract

Aberrant epigenetic silencing of the tissue inhibitor of matrix metalloproteinase-3 (TIMP-3) gene that negatively regulates matrix metalloproteinases (MMPs) activity has been implicated in the pathogenesis and metastasis of breast cancer. In the present study, we demonstrate that green tea polyphenols (GTP) and its major constituent, epigallocatechin-3-gallate (EGCG) mediate epigenetic induction of TIMP-3 levels and play a key role in suppressing invasiveness and gelatinolytic activity of MMP-2 and MMP-9 in breast cancer cells. Treatment of MCF-7 and MDA-MB-231 breast cancer cells with 20 µM EGCG and 10 µg/mL GTP for 72 h significantly induces TIMP-3 mRNA and protein levels. Interestingly, investigations into the molecular mechanism revealed that TIMP-3 repression in breast cancer cells is mediated by epigenetic silencing mechanism(s) involving increased activity of the enhancer of zeste homolog 2 (EZH2) and class I histone deacetylases (HDACs), independent of promoter DNA hypermethylation. Treatment of breast cancer cells with GTP and EGCG significantly reduced EZH2 and class I HDAC protein levels. Furthermore, transcriptional activation of TIMP-3 was found to be associated with decreased EZH2 localization and H3K27 trimethylation enrichment at the TIMP-3 promoter with a concomitant increase in histone H3K9/18 acetylation. Our findings highlight TIMP-3 induction as a key epigenetic event modulated by GTPs in restoring the MMP:TIMP balance to delay breast cancer progression and invasion.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  breast cancer; enhancer of zeste homolog 2; green tea polyphenols; histone deacetylases; invasion; metastasis; tissue inhibitors of matrix metalloproteinase-3

Mesh:

Substances:

Year:  2014        PMID: 24481780     DOI: 10.1002/mc.22121

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  32 in total

1.  The Ezh2 polycomb group protein drives an aggressive phenotype in melanoma cancer stem cells and is a target of diet derived sulforaphane.

Authors:  Matthew L Fisher; Gautam Adhikary; Dan Grun; David M Kaetzel; Richard L Eckert
Journal:  Mol Carcinog       Date:  2015-12-23       Impact factor: 4.784

Review 2.  Epigenetic regulation by selected dietary phytochemicals in cancer chemoprevention.

Authors:  Samriddhi Shukla; Syed M Meeran; Santosh K Katiyar
Journal:  Cancer Lett       Date:  2014-09-16       Impact factor: 8.679

3.  Effects of Tea Catechins on Cancer Signaling Pathways.

Authors:  Chung S Yang; Hong Wang; Jayson X Chen; Jinsong Zhang
Journal:  Enzymes       Date:  2014

Review 4.  New targeted therapies for breast cancer: A focus on tumor microenvironmental signals and chemoresistant breast cancers.

Authors:  Armel Hervé Nwabo Kamdje; Paul Faustin Seke Etet; Lorella Vecchio; Richard Simo Tagne; Jeremie Mbo Amvene; Jean-Marc Muller; Mauro Krampera; Kiven Erique Lukong
Journal:  World J Clin Cases       Date:  2014-12-16       Impact factor: 1.337

5.  Current Perspectives on Epigenetic Modifications by Dietary Chemopreventive and Herbal Phytochemicals.

Authors:  Yue Guo; Zheng-Yuan Su; Ah-Ng Tony Kong
Journal:  Curr Pharmacol Rep       Date:  2015-08

Review 6.  Histone and Non-Histone Targets of Dietary Deacetylase Inhibitors.

Authors:  Eunah Kim; William H Bisson; Christiane V Löhr; David E Williams; Emily Ho; Roderick H Dashwood; Praveen Rajendran
Journal:  Curr Top Med Chem       Date:  2016       Impact factor: 3.295

Review 7.  Natural compound-derived epigenetic regulators targeting epigenetic readers, writers and erasers.

Authors:  Anne Yuqing Yang; Hyuck Kim; Wenji Li; Ah-Ng Tony Kong
Journal:  Curr Top Med Chem       Date:  2016       Impact factor: 3.295

Review 8.  Dietary phytochemicals as epigenetic modifiers in cancer: Promise and challenges.

Authors:  Eswar Shankar; Rajnee Kanwal; Mario Candamo; Sanjay Gupta
Journal:  Semin Cancer Biol       Date:  2016-04-23       Impact factor: 15.707

Review 9.  The Role of Epigenetic Modifications in Human Cancers and the Use of Natural Compounds as Epidrugs: Mechanistic Pathways and Pharmacodynamic Actions.

Authors:  Abdelhakim Bouyahya; Hamza Mechchate; Loubna Oumeslakht; Ikrame Zeouk; Sara Aboulaghras; Abdelaali Balahbib; Gokhan Zengin; Mohammad Amjad Kamal; Monica Gallo; Domenico Montesano; Nasreddine El Omari
Journal:  Biomolecules       Date:  2022-02-25

Review 10.  Polyphenols Modulating Effects of PD-L1/PD-1 Checkpoint and EMT-Mediated PD-L1 Overexpression in Breast Cancer.

Authors:  Samia S Messeha; Najla O Zarmouh; Karam F A Soliman
Journal:  Nutrients       Date:  2021-05-19       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.